A Tale of 2s: Optimizing Maternal-Child Health in the Context of Antenatal Maternal Depression and Antidepressant Use.

An introduction is presented in which the author discusses various reports within the issue on topics including risks associated with maternal depression during pregnancy, prenatal exposure to selective serotonin reuptake inhibitors (SSRIs) and molecular factors that influences hydroxytryptamine levels during gestation.